Skip to main content
SpringerLink
Log in

Spaf III Trial: Of Risk Stratification and Minimal Effective Warfarin Intensity

  • Published:
Cardiac Electrophysiology Review

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Albers GW. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Int Med 1994;154: 1443-1448.

    Google Scholar 

  2. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1989;1(8631):175-179.

    Google Scholar 

  3. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991;84:524-539.

    Google Scholar 

  4. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.

    Google Scholar 

  5. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C, for the CAFA Study Coinvestigators. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-355.

    Google Scholar 

  6. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazaarian SM, Radford MJ, et al., for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992; 327:1406-1412.

    Google Scholar 

  7. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, Creco FA, Huberman M, Moore C. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Int Med 1990; 112:423-428.

    Google Scholar 

  8. Poller L, McKernan A, Thomson JM, Elstein M, Hirsch PJ, Jones JB. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J 1987:295:1309-1312.

    Google Scholar 

  9. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-638.

    Google Scholar 

  10. Stroke Prevention in Atrial Fibrillation Investigators. Prospective identification of atrial fibrillation patients at low risk of stroke during treatment with aspirin: The SPAF-III aspirin low-risk cohort study [Abstract]. Circulation 1997, in press.

  11. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-546.

    Google Scholar 

  12. Lancaster T, Mant J, Singer DE. Stroke prevention in atrial fibrillation [editorial]. Br Med J 1997;314:1563-1564.

    Google Scholar 

  13. Hellemons BSP, Langenberg M, Lodder J, Vermeer F, Schouten HJA, van Ree JW, Knottnerus JA. Primary prevention of arterial thromboembolism in patients with nonrheumatic atrial fibrillation in general practice (The PATAF study). Cerebrovasc Dis 1997;7:1-88.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL

    Joseph L. Blackshear

Authors
  1. Joseph L. Blackshear
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blackshear, J.L. Spaf III Trial: Of Risk Stratification and Minimal Effective Warfarin Intensity. Card Electrophysiol Rev 2, 44–48 (1998). https://doi.org/10.1023/A:1009946608393

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009946608393

Keywords

Search

Navigation